中国社区医师Issue(26)：72-73,2.DOI:10.3969/j.issn.1007-614x.2014.26.44
阿奇霉素序贯疗法治疗小儿支原体肺炎临床疗效及安全性研究
Study on the clinical efficacy and safety of azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia
摘要
Abstract
Objective:To explore the clinical efficacy and safety of azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia.Methods:100 children with mycoplasma pneumonia were selected from September 2012 to September 2013.They were randomly divided into the A group and the B group with 50 cases in each.The A group were treated with azithromycin sequential therapy,and the B group were treated with erythromycin.We observed the effect of treatment and hospitalization and the symptoms disappeared time,and compared the adverse reactions of the two groups.Results:In the total efficiency of treatment,group A was 98%(49/50);group B was 80%(40/50);group A was significantly higher than that in group B(P<0.05).In the fever,pulmonary rales,cough disappeared time and hospitalization time,group A was significantly lower than that of group B(P<0.05).In the incidence of adverse reactions,group A was 6% (3/50);group B was 30% (15/50);group A was significantly lower than that of group B(P<0.05).Conclusion:The clinical efficacy of azithromycin sequential therapy in the treatment of children with mycoplasma pneumonia is significant.The adverse reaction is little,and security is high.It promotes the patient discharged and rehabilitation.So it has important clinical value in use.关键词
阿奇霉素序贯疗法/小儿支原体肺炎/红霉素/临床疗效/安全性Key words
Azithromycin sequential therapy/Children with mycoplasma pneumonia/Erythromycin/Clinical efficacy/Safety引用本文复制引用
陶汝萍..阿奇霉素序贯疗法治疗小儿支原体肺炎临床疗效及安全性研究[J].中国社区医师,2014,(26):72-73,2.
